Efficacy of cryotherapy as an adjunctive treatment for mandibular central giant cell granuloma: A case series
Advances in Oral and Maxillofacial Surgery · 2026-12 · 24 · 100738
DOI: 10.1016/j.adoms.2026.100738 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Oral and Maxillofacial Surgery, 2026-12. Verfasst von Richard Yang und 2 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This case series examines the clinical and radiographic outcomes of central giant cell granulomas (CGCG) of the mandible treated with enucleation, liquid nitrogen cryotherapy, and recombinant human bone morphogenetic protein-2 (rhBMP-2) augmented bone grafting. Five patients were treated with this surgical technique. All patients demonstrated complete radiographic ossification within 6–12 months, without recurrence or major complication. In all patients whose dentition was resected with the pathologic bone (2 of 5), complete dental rehabilitation was achieved, demonstrating functional bone regeneration. This series represents a reliable middle ground between curettage and segmental resection.
Zitieren
APA
Yang, R., Middleton, J., & Fallah, H. (2026). Efficacy of cryotherapy as an adjunctive treatment for mandibular central giant cell granuloma: A case series. Advances in Oral and Maxillofacial Surgery, 24, 100738. https://doi.org/10.1016/j.adoms.2026.100738
Vancouver
Yang R, Middleton J, Fallah H. Efficacy of cryotherapy as an adjunctive treatment for mandibular central giant cell granuloma: A case series. Advances in Oral and Maxillofacial Surgery. 2026;24:100738. doi:10.1016/j.adoms.2026.100738
BibTeX
@article{Yang2026,
author = {Yang, Richard and Middleton, Jason and Fallah, Heshaam},
title = {Efficacy of cryotherapy as an adjunctive treatment for mandibular central giant cell granuloma: A case series},
journal = {Advances in Oral and Maxillofacial Surgery},
year = {2026},
volume = {24},
pages = {100738},
doi = {10.1016/j.adoms.2026.100738}
}
EUVIMED